Diclofenac as a KMO Inhibitor

NCT06029296 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Alcohol Use Disorder

Interventions

DRUG: Diclofenac
DRUG: Placebo

Sponsor

University of Maryland, Baltimore